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Abstract
Individuals who carry a premutation (PM) allele on the FMR1 gene may experience
executive limitations associated with their genetic status, including inhibition deficits. However,
poor understanding of individualized risk factors has limited clinical management of this group,
particularly in mothers who carry the PM allele who have children with fragile X syndrome
(FXS). The present study examined CGG repeat length and age as factors that may account for
variable expressivity of inhibition deficits. Participants were 134 carriers of the PM allele who
were mothers of children with FXS. Inhibition skills were measured using both self-report and
direct behavioral assessments. Increased vulnerability for inhibition deficits was observed at
mid-range CGG lengths of approximately 80-100 repeats, with some evidence of a second zone
of vulnerability occurring at approximately 130-140 CGG repeats. Risk associated with the
genotype also became more pronounced with older age. This study identifies personalized risk
factors that may be used to tailor the clinical management of executive deficits in carriers of the
PM allele. Inhibition deficits may contribute to poor outcomes in carriers of the PM allele and
their families, particularly in midlife and early old age, and clinical monitoring may be
warranted.

Keywords: fragile X premutation carrier; executive dysfunction; age effects; FMR1 premutation;
mid-range CGG
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We examined inhibition skills in mother carriers of the FMR1 premutation.
Mid-range CGG repeats of ~80-100 were associated with greater inhibition deficits.
Older age was also linked with inhibition deficits, beyond the effect of CGG size.
Mid-range CGG’s and older age could be personalized risk factors for carriers.
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Inhibition Deficits are Modulated by Age and CGG Repeat Length in Carriers of the
FMR1 Premutation Allele who are Mothers of Children with Fragile X Syndrome
1. Introduction
Over one million individuals in the United States are genetic carriers of a premutation
(PM) allele on the Fragile X Mental Retardation-1 (FMR1) gene (Maenner et al., 2013). Carriers
of the PM allele have 55-200 CGG repeats on the FMR1 gene on the X chromosome, which
represents an expansion beyond the normal range of 6-54 CGG repeats (Maddalena et al., 2001).
PM expansion of the FMR1 CGG sequence is associated with molecular genetic abnormalities,
such as decreased production of the protein encoded by FMR1, Fragile X Mental Retardation
Protein (FMRP; Kenneson, Zhang, Hagedorn, & Warren, 2001; Oh et al., 2015; Primerano et al.,
2002) and elevated levels of FMR1 mRNA (Garcia-Arocena & Hagerman, 2010; Kenneson et
al., 2001; Tassone et al., 2000). Accumulating evidence now supports the PM allele as a
genotype that is associated with clinical risk, although varying symptom severity and age of
symptom onset, as well as incomplete penetrance, has made it difficult to pinpoint the full range
of associated clinical features (Movaghar et al., 2019; Wheeler, Raspa, Hagerman, Mailick, &
Riley, 2017; Wheeler et al., 2014).
Delineating the phenotype as manifested in female carriers of the PM allele is of
particular importance given that PM alleles are about twice as likely to occur in females
compared to males (Hunter et al., 2014). Moreover, female carriers of the PM allele can pass an
expanded version of the affected gene to their children, causing fragile X syndrome (FXS)—an
inherited form of intellectual disability (Fu et al., 1991). Understanding the presentation of PM
symptoms in mothers of children with FXS is critically important because the clinical effects of
the PM allele may have implications not only for the mother’s health but also for her ability to
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care and advocate for her children living with FXS. Understanding the clinical phenotype of
carriers of the PM allele as manifested in mothers of children with FXS is essential to the
development of family-centered treatments that target the specific needs of carriers of the PM
allele and their families. Moreover, carriers of the PM allele who are mothers of children with
FXS may be more vulnerable to poor outcomes in general, due to the combined effects of genetic
risk coupled with the added environmental stressors associated with parenting a child with a
disability (e.g., Seltzer et al., 2012). In sum, the clinical significance of the PM allele may be
elevated among mothers of children with FXS due to the broader family context in which it
occurs.
The FMR1 PM allele confers risk for two well-established genotype-specific conditions:
Fragile X-Associated Primary Ovarian Insufficiency (FXPOI) and Fragile X-Associated
Tremor/Ataxia Syndrome (FXTAS). FXPOI affects approximately 20% of female carriers of the
PM allele and is characterized by early menopause, hormonal disruption, and fertility problems
(Sullivan, Welt, & Sherman, 2011). FXTAS is a late-onset neurodegenerative disorders that
occurs in approximately 17% of female carriers of the PM allele and is characterized by tremor,
ataxia, cognitive decline, and associated neuropathological features that include white matter
degeneration, global brain atrophy, and intranuclear inclusions throughout the cortex and
brainstem (Greco et al., 2005; Halket, Wang, Hessl, & Rivera, 2016; Rodriguez-Revenga et al.,
2009). Other documented clinical consequences of the FMR1 PM genotype in women who have
children with fragile X include elevated risk for depression, anxiety, and physical health
problems such as hypertension and migraines (Bourgeois et al., 2011; Hagerman & Hagerman,
2013; Roberts et al., 2016). Mild autism-related features, including difficulties with eye contact
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and the social use of language, are also elevated in this group (Klusek, Fairchild, & Roberts,
2019; Klusek, Ruber, & Roberts, 2018; Losh et al., 2012).
Executive deficits in working memory, attention, and inhibition have been reported in
female carriers of the PM allele, although the executive phenotype in females is controversial
due to inconsistencies across reports (e.g., Hunter et al., 2008). Neuroimaging evidence from
carriers of the PM allele lends support for executive deficits associated with this genotype, as
evidenced by structural, microstructural, and functional differences in brain regions important for
executive functions. For example, white matter abnormalities have been implicated in attenuated
performance on a range of executive tasks (Gunning-Dixon & Raz, 2000), and are observed in
frontal, parietal, and cerebellar pathways in both male and female carriers of the PM allele who
do not have FXTAS (Battistella et al., 2013; Hashimoto, Srivastava, Tassone, Hagerman, &
Rivera, 2011; Leow et al., 2014). Some reports have detected associations between white matter
abnormalities in female carriers of the PM allele and FMR1-related molecular indices (mRNA
levels and methylation of the FMR1 exon 1/intron 1 boundary), suggesting that these differences
in brain structure may arise due to genetic risk associated with the PM allele (Shelton et al.,
2017). White matter microstructure in the corpus callosum and cerebellar peduncles, and
disruption of diffusion network measures in the left superior parietal cortex, have been reported
as correlates of performance on executive functioning measures in female carriers of the PM
allele who were asymptomatic for FXTAS (Leow et al., 2014; Shelton et al., 2017). Moreover,
reduced activation in pre-frontal and frontal-parietal regions—areas important for executive
function—has been observed in female carriers of the PM allele during completion of a various
executive tasks and are associated with specific FMR1 molecular genetic markers (Hashimoto,
Backer, Tassone, Hagerman, & Rivera, 2011; Kim, Hashimoto, Tassone, Simon, & Rivera,
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2013). Overall, neuroimaging studies of female carriers of the PM allele suggest the presence of
structural, microstructural, and functional differences in brain regions that are implicated in
executive functions, and which appear to be linked to FMR1-related molecular genetic
alterations.
Behavioral studies of executive skills in female carriers of the PM allele suggest that
deficits in inhibition, or the suppression of automatic or preplanned responses (Aron, 2011), are
perhaps the most widely documented executive deficit. This body of evidence suggests poorer
performance than matched controls on tasks requiring verbal, visual, or motor suppression of
prepotent responses (Kraan, Hocking, Georgiou‐Karistianis, et al., 2014; Shelton et al., 2014;
Yang et al., 2013). Yet, findings have been mixed, with some studies failing to detect inhibition
differences in female carriers of the PM allele (see Hunter et al., 2008; Wheeler et al., 2017).
Clarifying these discrepancies is important given that inhibition deficits can impact performance
in social and occupational contexts, and are linked with a host of maladaptive behaviors
including substance abuse, suicidal ideation, criminal conduct, and antisocial behavior
(Feilhauer, Cima, Korebrits, & Kunert, 2012; Meza, Owens, & Hinshaw, 2016; Rubio et al.,
2008; Tremblay, Pihl, Vitaro, & Dobkin, 1994; Verdejo-García, Lawrence, & Clark, 2008).
One source of inconsistency in the extant literature may be variation due to measurement
techniques. It has been argued that tasks that require rapid, on-line recruitment of executive skills
have increased sensitivity to PM-associated executive difficulties relative to tasks that do not
impose time constraints, underscoring the need for multimodal assessment in future work (e.g.,
Kraan, Hocking, Bradshaw, et al., 2014; Shelton et al., 2016). Discrepant findings may also be
due, in part, to differing sample characteristics across studies, such as the age of the sample
members. Many prior reports have focused on samples consisting of young-adult and middle-
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aged women, while evidence suggests that PM-associated symptoms may become more
prominent at older ages. Age-related decline in cognitive-executive functioning has been
suggested in some emerging reports. For example, older age is correlated with reduced language
fluency and lower scores on magnitude comparison and numerical enumeration tasks in female
carriers of the PM allele, but not among age-matched controls (Goodrich-Hunsaker, Wong,
McLennan, Srivastava, et al., 2011; Goodrich-Hunsaker, Wong, McLennan, Tassone, et al.,
2011; Sterling, Mailick, Greenberg, Warren, & Brady, 2013).
However, few prior investigations have examined the impact of aging on inhibition skills
specifically. In one report by Kraan, Hocking, Georgiou‐Karistianis, et al. (2014), a correlation
between older age and verbal inhibition errors was detected in female carriers of the PM allele
(n=35), although the association did not survive correction for multiple comparisons. Few other
investigations have focused on females, although age-inhibition associations have also been
noted in male carriers of the PM allele (Hunter, Sherman, Grigsby, Kogan, & Cornish, 2012).
Thus, the extant literature is inconclusive and follow-up is needed to better understand the profile
of age-related vulnerability in female carriers of the PM allele.
The length of the PM CGG repeat expansion is another factor that may relate to
variability in the expression of inhibition deficits. PM expansion of the CGG sequence leads to
molecular genetic alterations such as elevated mRNA and decreased FMRP (Kenneson et al.,
2001; Oh et al., 2015; Primerano et al., 2002). These changes in gene function are thought to
underlie phenotypic expression (Hagerman & Hagerman, 2013), and may vary according to the
length of the CGG repeat expansion within the PM range (Chen, Tassone, Sahota, & Hagerman,
2003; Kenneson et al., 2001; Loesch et al., 2007; Sellier et al., 2014). Thus, the size of the CGG
expansion may provide important information regarding individualized risk profiles, including
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risk for inhibition difficulties. One report by Shelton et al. (2014) reported a correlation between
ocular-motor inhibition errors and CGG repeat length, where errors were the highest at the lower
end of the PM range and decreased linearly as the length of the CGG expansion increased.
However, evidence is mixed, as not all reports have detected CGG-related variation in inhibition
skills (Kraan, Hocking, Georgiou‐Karistianis, et al., 2014; Yang et al., 2013). Notably, most
prior studies have been limited by small samples that were characterized by poor representation
at the low and high ends of the PM CGG range, and as a result were unable to test for nonlinear
associations. This is critical because curvilinear CGG relationships have been reported relative to
other aspects of PM phenotype, with risk for clinical involvement the highest at mid-range PM
repeat lengths (approximately 80-110) and lower at the tails (Ennis, Ward, & Murray, 2006;
Klusek, Porter, et al., 2018; Mailick, Hong, Greenberg, Smith, & Sherman, 2014; Roberts et al.,
2009; Seltzer et al., 2012). Only one prior report has probed for nonlinear CGG-inhibition
relationships, with inconclusive results. In a study of 37 female carriers of the PM allele, Klusek
et al. (2018) detected a trend where verbal inhibition errors were the most pronounced in carriers
with approximately 60-80 CGG repeats, decreased by degree from approximately 80-120 CGG
repeats, and began to increase again at CGG repeat sizes greater than approximately 120.
Follow-up studies incorporating larger sample sizes are needed to clarify potential CGG-related
modulation of inhibition skills in female carriers of the PM allele.
The present study represents the largest investigation to date of inhibition skills in female
carriers of the PM allele. Including a sample of over 130 carriers of the PM allele, we aim to
clarify the effect of age and CGG repeat length on the expression of inhibition deficits in this
group. We focused on carriers of the PM allele who are mothers of a child with FXS (hereafter
referred to as “PM mothers of children with FXS”)—a subgroup of women who may be
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particularly vulnerable to poor outcomes due to the coupling of genetic risk with elevated stress
exposure associated with parenting a child with a disability (e.g., Seltzer et al., 2012). The study
of the clinical phenotype of PM mothers of children with FXS is of particular importance
because of broader family context in which it occurs; mothers are often the primary caregiver for
their children and the clinical effects of the PM allele in mothers can impact health and quality of
life for both the mother as well as her children with FXS. To address potential measurement
effects that may account for discrepancies across prior reports, we adopt a multimodal approach
that incorporates both self-report and direct assessment indices of inhibitory control, including
measurement of response latency as well as errors. The effort to identify individual risk factors
that relate to inhibition deficits in carriers of the PM allele is consistent with a personalized
medicine approach and may have implications for understanding individual risk profiles and the
eventual application of tailored counseling and prevention efforts. Our specific research
questions were: (1) Are inhibition skills associated with FMR1 CGG repeat length in PM
mothers of children with FXS?; (2) Is older age associated with poorer inhibition skills in PM
mothers of children with FXS? Consistent with prior reports of vulnerability at mid-range PM
CGG repeat lengths, we expected inhibition skills to be most impaired in mothers with CGG
repeat lengths of approximately 80-110. We also hypothesized that older age would relate to
greater inhibition difficulties.
2. Methods
2.1 Participants
Participants in the present study included 134 female carriers of PM allele who were
biological mothers of a child with FXS. Participants were drawn from a larger ongoing research
study, Family Adaptation to Fragile X Syndrome, which focused on the adaptation of families of
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adolescents and adults with FXS (Mailick et al., 2018; Seltzer et al., 2012; Smith, Hong,
Greenberg, & Mailick, 2016). One hundred of the present sample of 134 participants were
recruited in 2008 and have been studied four times since then. Data for the present analysis were
drawn from the study’s fourth wave of data collection (2016-2018). These participants resided in
38 U.S. states and one Canadian province, and were recruited through fragile X support groups,
university-based disability research registries, and advertisement at clinics, service agencies, and
national disability organizations. An additional 34 participants were enrolled in the study through
a supplementary recruitment effort begun in 2016; their children were patients at the fragile X
clinic at the Rush University Medical Center.
To be included in the present analysis, the mother’s CGG repeat number had to be
between 55 and 200 (i.e., within the PM range) and she had to be the biological mother of a child
with FXS who was confirmed to have the full mutation (>200 CGG repeats in 5’UTR of FMR1)
via review of medical records. The mean age of the children with FXS was 27 years (SD = 9,
range = 12-62 years). Consistent with the broader goals of the Family Adaptation to Fragile X
Syndrome project, our focus was on mothers of adolescent and adult-aged children. FXS is a
lifelong disability and the caregiving responsibilities of parents of children with intellectual and
developmental disabilities often span several decades, persisting even as parents reach midlife
and early old age (Namkung, Greenberg, Mailick, & Floyd, 2018; Seltzer, Floyd, Song,
Greenberg, & Hong, 2011). Thus, the need for family-centered interventions to support
individuals with FXS and their caregivers continues across the life course. Descriptive and
demographic characteristics of the sample are presented in Table 1.

Table 1
Demographics and Descriptives
Variable

n = 134

INHIBITION DEFICITS IN FMR1 PREMUTATION MOTHERS
Age in years
M (SD)
Range
Household Income
<40k
40-59k
60-79k
80-99k
100-139k
>139k
Highest Education Level
High school graduate or less
Some college
Bachelor’s degree
Some graduate school or higher
Race
White
Black or African American
Asian, Pacific Islander or Native Hawaiian
American Indian or Alaskan Native
Other

12

56.79 (8.65)
39.00-88.00
12%
12%
12%
19%
19%
26%
10%
24%
28%
38%

94%
3%
1%
1%
1%

2.2 Procedures
Participants completed paper-and-pencil questionnaires and provided buccal swabs for
DNA analyses, which were returned to the researchers via the mail. The assessment also
consisted of an audio-recorded telephone interview that lasted about an hour. The Hayling
Sentence Completion Test (Burgess & Shallice, 1997) was administered over the phone as part
of the telephone interview. The Hayling has been widely used as a sensitive index of inhibition
deficits in studies of carriers of the PM allele (Cornish et al., 2015; Hunter et al., 2012; Kraan,
Hocking, Georgiou‐Karistianis, et al., 2014). While this task has not been standardized for phone
administration, neuropsychological assessment via the phone has been supported as a valid and
reliable mode of evaluation for other cognitive-executive batteries that have been administered to
the general population, such as the Brief Test of Adult Cognition by Telephone (BTACT;
(Lachman, Agrigoroaei, Tun, & Weaver, 2014). Raw Hayling scores are used in analysis and
standard scores are interpreted with caution given the non-standard administration. All subjects
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provided written informed consent in accordance with the Declaration of Helsinki. Procedures
were approved by the Institutional Review Boards of the University of Wisconsin-Madison and
the Marshfield Clinic Research Institute.
2.3 Evaluation of Inhibition Skills
Hayling Sentence Completion Test (Burgess & Shallice, 1997). The Hayling was
administered as a direct-assessment measure of response inhibition. In this assessment,
participants are read 15 sentences that have the final word of the sentence missing. Participants
are asked to provide a word that is unconnected to the meaning of the sentence as quickly as
possible, requiring participants to suppress a prepotent verbal response. Performance was
indexed in terms of two variables: response latency and errors. Response latency was quantified
as the time in seconds to inhibit the prepotent verbal response and provide an alternative
response. Longer latency reflects poorer inhibition skills. Errors on the Hayling were recorded as
category A errors (responses closely connected to the sentence) and category B errors (responses
loosely connected to the sentence). The converted A+B error score was computed as described
by the test developers; this score weights errors for frequency and severity. Converted error
scores can range from 0-78, with higher scores indicating that errors were more frequent or more
severe. Errors on the Hayling have been shown to differentiate female carriers of the PM allele
from neurotypical controls in prior work (Cornish et al., 2015; Kraan, Hocking, Georgiou‐
Karistianis, et al., 2014), whereas Hayling latency scores have not been thoroughly examined in
this population. In this study we focused on both error and latency scores, in line with the recent
argument that temporal response time has a substantial influence on the executive performance
of female carriers of the PM allele (Shelton et al., 2016).
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Response latency was recorded by the examiner live during the telephone interview, and
later checked off-line by an independent coder who reviewed the audio recordings and made
corrections to the live scoring as necessary. Errors were coded off-line by the independent coder.
Twenty percent of samples were randomly selected and scored by a second independent coder
for reliability. Inter-rater reliability was substantial for both latency scores (κ = 0.91) and error
classification (ICC [3,1] = 0.99). Hayling data were missing for one participant who did not
complete the phone interview portion of the study.
Behavior Rating Inventory of Executive Function- Adult Version (BRIEF-A; Roth &
Gioia, 2005). The Inhibit subscale of the BRIEF-A provided a self-report measure of inhibition.
The Inhibit subscale consists of 8 items that capture impulse control and the ability to
appropriately stop one’s own behavior at the proper time, such as waiting for one’s turn. Items
are scored on a 3-point scale denoting the extent to which each problem is experienced in daily
life. T-scores were computed; scores at or above 65 are considered clinically significant.
Following the verification procedures outlined in the BRIEF-A manual, data were considered
invalid if high scores were obtained on either the negativity or infrequency scales. This resulted
in missing BRIEF-A data for four participants.
2.4 Evaluation of FMR1 CGG Repeat Length
Buccal swabs were analyzed for DNA using standard methods. FMR1 CGG genotyping
was conducted with the Asuragen AmplideX® Kit (Chen et al., 2010; Grasso et al., 2014).
Analyses were conducted at Rush University Medical Center in the laboratory of Dr. Elizabeth
Berry-Kravis.
2.5 Analysis Plan
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Analyses were conducted in SAS v9.4 (SAS Institute, 2013). Descriptive statistics were
computed and the variables were examined for distribution. Normal distribution was observed
for all inhibition variables except the Hayling error score which showed significant right
skewing. A BoxCox power transformation (Box & Cox, 1964) of λ= -0.25 was applied to correct
the Hayling error score. However, analyses conducted on the original vs. transformed variable
yielded identical inferential results so only analyses based on the untransformed data are
presented. The distribution of CGG repeat length was characterized by an extreme outlier that
fell more than three times outside the interquartile range above the third quartile. This data point
had a CGG repeat length of 186, which was considerably higher than the CGG lengths of all
other cases (67-138 repeats). In all statistical models including CGG repeat length as a variable
of interest, regression diagnostics indicated that this case had an unduly large influence on the
regression coefficients, as indicated by a Cook’s Distance value that was considerably larger than
the Distance value of all other cases and far exceeded the recommended cut-off criteria of Di
>4/n-k-1 (Cook, 1977). Given its undue influence on the model results, this highly influential
point was excluded from all analyses. Dropping this outlier was viewed as a conservative
approach that avoided estimating patterns occurring at high CGG repeat lengths based on
information gleaned from a single data point.
Next, preliminary analyses were conducted to inform model specification. A Pearson’s
correlation matrix was computed to inform the intercorrelation among variables of interest.
Recruitment source (i.e., whether participants were drawn from the longitudinal family
adaptation study that began in 2008 or as part of the supplemental recruitment in 2016) was also
explored as a potential confound. Participants recruited in 2016 were younger, on average, than
the participants recruited in 2008. No other differences were detected across the two samples on
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any of the inhibition or genetic variables. Based on these preliminary analyses, recruitment
source was not covaried in the final models to preserve degrees of freedom.
To test the first research question regarding the effect of CGG repeat length on inhibition
skills, a series of general linear models were fit to test CGG repeat length on the PM allele as a
predictor of each of the inhibition variables. Education level was included as a covariate, coded
as a four-level categorical variable (high school graduate or less, some college, bachelor’s
degree, some graduate school or higher). Given prior reports of curvilinear risk patterns (Klusek,
Porter, et al., 2018; Mailick et al., 2014; Roberts et al., 2009; Seltzer et al., 2012), quadratic and
cubic CGG terms were probed to test for nonlinear relationships. Higher-order polynomial terms
were successively added to the model and retained if they accounted for significant variance and
visual examination of fit plots indicated improved model fit. Effect sizes were computed for all
general linear models. In general, partial eta squared (η2p) values of 0.01, 0.06, and 0.14 are
interpreted as “small”, “medium”, and “large” in size (Cohen, 1988).
Next, analyses were conducted to address the second research question regarding the
effect of age on inhibition. General linear models tested age as a predictor of each of the
inhibition variables, controlling for education level. To determine if age was an independent
predictor beyond the effect of CGG repeat length, age was also added as a predictor to the
curvilinear CGG models specified for the first research question. In addition, preliminary
analyses tested for possible interactions between age and nonlinear CGG, to determine whether
the effect of age on inhibition varied nonlinearly at different levels of CGG repeat lengths. For
this analysis CGG repeat length was re-coded into categories of low (55-89), mid-size (90-110),
and high (111-200) CGG repeats, consistent with the approximate zone of mid-size vulnerability
identified in prior reports (Allen et al., 2007; Mailick et al., 2014; Sullivan et al., 2005). General
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linear models were fit testing age, the categorical CGG variable, and their interaction, as
predictors of inhibition skills, controlling for education level. Categorical modeling of CGG
repeat length was used in this analysis in order to preserve statistical power (modeling age
interactions across the polynomial CGG terms would have required the inclusion of multiple
interaction terms, limiting degrees of freedom).
3. Results
3.1 Descriptive Statistics
Descriptive statistics are presented in Table 2. The average CGG repeat length on the PM
allele was 93, with a range of 67-138. Eight percent of the sample obtained Hayling response
latency scores falling at or below the 5th percentile, which corresponds to scaled scores classified
within the “Impaired”, “Abnormal”, or “Poor” ranges, as described in the test manual (Burgess
& Shallice, 1997). Twenty-five percent obtained Hayling error scores falling at or below the 5th
percentile. Five percent of participants obtained Inhibit subscale scores on the BRIEF-A that fell
within the clinically significant range (i.e., t-score ≥65). A Pearson’s correlation matrix is
presented in Table 3.

Table 2. Descriptive statistics
Descriptive Statistic
Variable

N

M (SD) Range

Hayling Latency Score

132

49 (33) 1-184

Hayling Error Score

132

10 (13)

0-56

BRIEF-A Inhibit Subscale t-score

129

51 (8)

38-82

CGG Repeat Length

133

93 (15) 67-138

Table 3. Correlation matrix
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Variable

1.

2.

1. Hayling Latency Score

1.00

2. Hayling Error Score

.43* 1.00

3. BRIEF-A Inhibit Subscale t-score

.00

4. CGG Repeat Length
5. Age
*p < .050

3.

18
4.

.05

1.00

-.22* -.07

-.06

1.00

.26*

-.02

-.19*

.11

5.

1.00

3.2 Relationship between CGG Repeat Length and Inhibition Skills
The overall model testing CGG repeat length as a predictor of the Hayling error score
was not significant (F [6, 125] = 1.41, p = .214, R2 = .06). However, the overall model testing
CGG repeat length as a predictor of Hayling latency was significant with the cubic model
demonstrating the best fit, F (6, 125) = 2.73, p = .016, R2 = .11. The linear (p =.010, η2p =0.05),
quadratic (p =.010, η2p =0.05), and cubic terms (p =.011, η2p =0.05) for CGG length accounted
for significant variance in Hayling latency, with small-to-medium effect sizes. Education level
did not contribute significantly to the model (p =.651, η2p =0.01). The curvilinear association
between CGG length and latency is illustrated in Figure 1. Response latency was increased at
approximately 80-90 CGG repeats. Latency decreased as CGG length increased from
approximately 90-115 repeats, and then began to increase again at CGG repeat lengths above
approximately 130. See Table 4 for model results.

Table 4. Model results: Effect of CGG repeat length on the Hayling inhibition variables
Type III Sum of Squares
Hayling Latency
Score
Predictor

Hayling Error Score

F

p

η2p

F

p

η2p

Education level

0.55

.651

0.01

2.49

.064

0.06

Linear CGG

6.86

.009*

0.05

0.09

.761

0.00
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Quadratic CGG

6.79

.010*

0.05

0.10

.751

0.00

Cubic CGG

6.53

.012*

0.05

0.10

.747

0.00

*p < .050
Next, a general linear model was fit to test CGG repeat length as a predictor of
performance on the BRIEF-A Inhibit subscale. For this model, the addition of the cubic CGG
term did not result in improved model fit and therefore the quadratic model was selected as the
final model. Together, the terms for education level, linear CGG, and quadratic CGG accounted
for significant variance in performance on the BRIEF-A Inhibit subscale (F [5, 123] = 2.30, p =
.049, R2 = .09). Significant effects were observed for both the linear CGG term (p =.047, η2p =
0.03) and the quadratic CGG term (p =.042, η2p = 0.03). Education level also accounted for
significant variance in the model, with a medium effect size (p =.030, η2p =0.07). Participants
who had completed some college scored higher on the Inhibit subscale (signifying greater
impairments in inhibition) than participants in any other education level category (p’s < .027).
Figure 2 demonstrates the quadratic association between CGG length and scores on the Inhibit
subscale. Inhibition deficits were most pronounced at mid-size CGG lengths of approximately
90-110 repeats, with better inhibition skills reported at lower and higher CGG repeat sizes.
3.3 Impact of Older Age on Inhibition
Linear age effects were tested as a predictor of each of the inhibition measures,
controlling for education level. Model results are presented in Table 5. Older age was a
significant predictor of longer response latency on the Hayling, with a medium effect size (p
=.003, η2p = 0.07), but did not predict Hayling errors or scores on the BRIEF-A Inhibit subscale.
Table 5. Model results: Effect of age on the inhibition measures
Type III Sum of Squares
Hayling Latency
Score

Hayling Error
Score

BRIEF-A Inhibit
Subscale
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Predictor
Education level
Age
*p < .050

20

F

p

η2p

F

p

η2p

F

p

η2p

0.73

.535

0.02

2.61

.054

0.06

2.38

.073

0.05

9.00

.003* 0.07

1.44

.234

0.01

0.20

.660

0.00

3.4 The Combined Effect of Older Age and CGG Repeat Length on Inhibition Skills
In order to test the combined effect of age and CGG repeat length on inhibition skills, age
was added as a predictor to models testing the effect of CGG repeat length on the inhibition
outcomes. First, age was added as a predictor, along with education level and the linear,
quadratic, and cubic CGG terms, in the general linear model predicting Hayling latency. The
overall model was significant, F (7, 124) = 3.45, p = .002, R2 = .16. Age accounted for significant
variance in response latency with a small-medium effect size, even after education level and the
curvilinear effect of CGG repeat length was accounted for in the model (p = .009, η2p =0.05).
Model results are provided in Table 6 and graphically illustrated in Figure 3. Older age was
associated with longer response latency. Probing of the interaction between age and CGG repeat
length category (low, mid, high) did not yield evidence that the effect of age differed at different
levels of CGG repeat length (p = .391, η2p =0.02). Thus, age and CGG repeat number had
independent effects on Hayling latency, where older age and mid-range CGG repeats both
predicted longer latency.
Age did not account for significant variance when added to the model testing CGG as a
predictor of the Hayling error score outcome (p = .279, η2p < 0.01) or BRIEF-A Inhibit subscale
outcomes (p = .621, η2p < 0.01). Probing of the interaction between age and CGG repeat length
category did not yield evidence that the effect of age differed according to CGG repeat length for
either the Hayling error outcome (p = .796, η2p < 0.01) or the BRIEF-A Inhibit subscale (p =
.326, η2p = 0.02)
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Table 6. Model results: Combined effect of age and CGG repeat length on the Hayling latency
score
Type III Sum of Squares
Variable
F
p
η2p
Education level

0.52

.669

0.01

Linear CGG

6.87

.009*

0.05

Quadratic CGG

6.77

.010*

0.05

Cubic CGG

6.50

.012*

0.05

Age

6.97

.009*

0.05

*p < .050

4. Discussion
This study represents the largest multimodal investigation conducted to date of inhibition
skills in PM mothers of children with FXS. We detected increased vulnerability for inhibition
deficits among older mothers and those who carried mid-range CGG lengths of approximately
80-100 repeats. Results also suggest a possible increase in risk occurring at approximately 130140 repeats. This study enhances understanding of older age and mid-range PM CGG repeat
length as personalized risk factors that may inform the clinical management of the FMR1 PM in
mothers of children with FXS. Clinical monitoring of the progression of PM-associated
executive symptoms may be warranted during the transition from middle to older age,
particularly for those carrying mid-range CGG repeat sizes. Future study of the functional
consequences of inhibition deficits across mid-to-late adulthood will further clarify the clinical
significance of this work for PM mothers and their children with FXS.
4.1 Vulnerability at Mid-range CGG Repeat Lengths
To our knowledge, this is the first study to detect increased vulnerability for executive
deficits among individuals with mid-range CGG repeat lengths (approximately 80-100), relative

INHIBITION DEFICITS IN FMR1 PREMUTATION MOTHERS

22

to lower or higher PM repeat sizes. This mid-range vulnerability was evident across both selfreport and direct-assessment indices of inhibition. It was particularly striking on the Hayling
Sentence Completion Test where individuals with mid-range CGG repeats took approximately
30 seconds longer to inhibit a prepotent verbal response and provide an alternative response
relative to individuals with lower or higher repeat sizes. Thus, we add inhibition deficits to the
growing list of PM-associated symptoms that are more pronounced among individuals carrying
mid-range repeat sizes. This list also includes mental health involvement, early reproductive
aging, and problems with language production (Allen et al., 2007; Ennis et al., 2006; Klusek,
Porter, et al., 2018; Mailick et al., 2014; Roberts et al., 2016; Seltzer et al., 2012; Sterling et al.,
2013). The fact that the relationship between CGG repeat length and inhibition skills was
curvilinear may also account for some inconsistencies in prior investigations of CGG-dependent
variation in executive skills, which have relied primarily on tests of linear association (e.g.,
Kraan, Hocking, Georgiou‐Karistianis, et al., 2014; Shelton et al., 2014; Yang et al., 2013).
Despite growing evidence from this study and prior reports of increased risk of certain
phenotypes at mid-range CGG repeat sizes, the mechanisms underlying this vulnerability are
unclear. CGG-dependent changes in gene expression could play a role; FMR1 transcript and
protein levels have been shown to vary across the continuum of CGG repeat sizes (Chen et al.,
2003; Kenneson et al., 2001; Loesch et al., 2007; Sellier et al., 2014), with some evidence of
increased protein production at mid-range repeat sizes relative to other repeat sizes in the PM
range (Peprah et al., 2010). However, this possible explanation cannot be investigated in the
present study due to the lack of FMRP and mRNA data, which is a limitation. It is also possible
that mid-range vulnerability is related to hormonal dysfunction associated with the increased risk
for FXPOI that occurs within the CGG range (Allen et al., 2007; Lekovich et al., 2018); future
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investigations may explore this hypothesis. Another consideration is the potential for geneenvironment interactions. There is good evidence that women with mid-range CGG repeat sizes
are more vulnerable to the negative effects of environmental stress exposure (Hartley et al.,
2012; Seltzer et al., 2012) and less able to derive benefit from positive environmental factors
(Hartley, DaWalt, Hong, Greenberg, & Mailick, in press). The women in our study all had a
child with FXS and may have been more vulnerable to poor outcomes due to parenting stress
exposure. Future studies may explore whether similar patterns of phenotypic expression are
observed among women who do not have children with FXS.
4.2 Increased Inhibition Deficits Occurring at >130 CGG Repeats
Knowledge of CGG-dependent phenotypes occurring at “high” PM repeat lengths
(approximately 110-200) is relatively limited, given that these repeat sizes occur more rarely in
the population and are poorly represented in research samples. The current study was also
limited by poor representation across 140-200 CGG repeats. However, we did have good
representation across 110-140 repeats, which is a strength that may have allowed us to detect
cubic associations when others have not. In addition to detecting increased inhibition deficits at
mid-range CGG repeat sizes, we also observed a second rise in Hayling latency scores as CGG’s
increased from approximately 130-140 repeats. It is unclear whether this rise would continue
beyond 140 repeats, as we cannot infer patterns beyond the limits of our data. Ours is not the first
report to suggest a rise in inhibition deficits occurring at greater than approximately 130 CGG
repeats. In an independent sample, Klusek, Porter, et al. (2018) detected a trend-level cubic
association between CGG length and Hayling errors where symptoms increased at mid-range
CGG sizes and again at greater than 120 repeats. Taken together, findings suggest complex
nonlinear risk patterns for certain PM phenotypes, characterized by peaks and valleys of relative
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risk occurring across the range of CGG repeat lengths. The reasons for increased risk at greater
than 130 repeats are unclear, although decreased FMRP production related to ribosomal stalling
that occurs in the upper PM CGG range could be implicated (Kenneson et al., 2001; Tassone et
al., 2000). Delineating zones of phenotypic vulnerability may translate back to basic science
research aimed at identifying the molecular genetic properties that distinguish CGG repeat size
ranges.
4.3 Premature Cognitive Aging in Carriers of the PM Allele
Older age was associated with slower Hayling responses in PM mothers of children with
FXS. Age-related slowing in Hayling latency has also been observed in normal aging, with age
accounting for about 10% of variation in performance (Andrés & Van der Linden, 2000; Bielak,
Mansueti, Strauss, & Dixon, 2006; Treitz, Heyder, & Daum, 2007). However, in normal aging,
scores tend to be relatively stable through middle adulthood and pronounced slowing is not
evident until the 60’s (Treitz et al., 2007). In contrast, we observed age-related decline in PM
mothers of children with FXS beginning as early as the fourth decade of life and continuing with
each passing decade. Older mothers who carried mid-range CGG repeat sizes were most at risk,
given that both age and CGG repeat exerted an independent effect on inhibitory control. These
results may inform a personalized medicine approach to counseling, prevention, and treatment of
PM mothers of children with FXS.
It will be informative in future work to address how age-related decline in executive
skills may correspond to age-related neuroanatomical changes in PM mothers of children with
FXS. In studies focused on male carriers of the PM allele, there is emerging evidence of atypical
age-related changes in brain structure and function, specifically degeneration in functional
activation in the temporoparietal area that is associated with aging (Brown, Basu, Whalley, Kind,
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& Stanfield, 2018) and accelerated age-related decreases in the volume of the cerebellum and
whole brain (Wang et al., 2017). Elucidating neural correlates of age-related executive deficits in
PM mothers of children with FXS will inform gene-brain-behavior pathways implicated in the
expression of neurodegenerative phenotypes associated with the PM genotype.
4.4 Measurement Effects
Although mid-range CGG repeat vulnerability was observed across both inhibition
indices, results did not always align across the Hayling and BRIEF-A. For example, only the
Hayling was sensitive to age effects and to the increase in symptoms occurring at >130 CGG
repeat lengths. Additionally, education effects were observed on the BRIEF-A but not the
Hayling, with patterns suggesting that individuals who started college but did not finish were
more likely to report executive limitations. Notably, the BRIEF-A inhibit subscale was not
correlated with the Hayling latency and error scores, suggesting that these indices may tap
different aspects of inhibitory control. It is possible that the Hayling latency score, which
captures rapid, time-dependent responses, may be more sensitive to PM-associated executive
deficits than are non-timed measures, as has been suggested by Shelton et al. (2016). Shelton et
al. (2016) also discussed the importance of white matter integrity in the speed of neural
processing (e.g., Turken et al., 2008) and proposed that specific difficulties on timed executive
tasks may be associated with the reduced white matter integrity within the neural tracts
connecting the prefrontal, parietal, and cerebellar regions that has been documented in male and
female carriers of the PM allele (e.g., Battistella et al., 2013; Hashimoto, Srivastava, et al., 2011;
Leow et al., 2014). Consistent with the findings of Shelton et al. (2016), our results across the
two Hayling indices also suggest that timing is important; response latency was more sensitive to
PM-associated executive deficits than were response errors. Latency may better reflect the
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efficiency of executive responses, as captured by the time required to suppress an irrelevant
competing response and generate a better response. In contrast, errors indicate whether
successful inhibition was achieved, but not the effort required to achieve it. In future work, the
adoption of multimodal assessment that includes measures of response efficiency as well as
errors will further our understanding of the nature of executive deficits in PM mothers of
children with FXS.
4.5 Strengths and Limitations
Strengths of the present study include wide age range represented in the large sample,
which was drawn from a variety of recruitment sources including the community as well as a
fragile X clinic. Though the sample was diverse in terms of education and household income, it
was limited by a lack of racial diversity. The wide range of CGG repeats represented is also a
strength, particularly at higher repeat lengths of 100-138 which are often poorly represented in
studies employing smaller samples. However, no participant included in analysis had a repeat
number of over 138 (we excluded one outlier of 186 repeats), which limited inferences that could
be drawn across the full range of PM CGG repeat sizes. Our sample also consisted of PM
mothers of children with FXS; future studies should explore whether patterns extend to carriers
of the PM allele who do not have children with FXS.
Our inclusion of both self-reports and behavioral tests to index inhibition is also a
strength and may shed light on some mixed findings in previous reports. However, it is unclear
how our results may have been influenced by phone administration of the Hayling. Although
phone administration limits our ability to compare our data to published Hayling norms, our use
of phone administration may also be viewed as a strength in terms of laying the groundwork for
future phone-based executive behavioral assessments in studies of carriers of the PM allele. This
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method also makes it possible to include women for whom travel to the testing site is not
possible due to their own or their child’s limitations. Despite our use of phone administration,
performance on the Hayling was highly sensitive to age and CGG-related modulation of
inhibition deficits in the present sample of PM mothers of children with FXS.
4.6 Conclusions
Patterns of mid-range CGG repeat size vulnerability have been reported relative to other
aspects of the PM phenotype, and this report is the first to extend our understanding of mid-range
vulnerability to the executive deficits experienced by PM mothers of children with FXS. Across
both self-report and direct assessment measures of inhibitory control, women carrying mid-range
CGG lengths of approximately 80-100 repeats exhibited increased inhibition deficits. Results
also suggested a possible second zone of CGG-repeat-size vulnerability occurring at 130-140
repeats. Risk associated with the genotype became more pronounced with older age, resulting in
the most severe deficits in older individuals who carried CGG repeat sizes of approximately 80100 and 130-140. Inhibition deficits can impact performance in everyday social and occupational
settings. Our results suggest that inhibition deficits may contribute to poor outcomes in PM
mothers of children with FXS and their families, particularly in midlife and the early years of old
age. This study supports older age and mid-range CGG repeat length as personalized risk factors
that may be used to tailor the clinical monitoring and management of executive deficits in PM
mothers of children with FXS.
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Figure 1. Curvilinear association between CGG repeat length and the Hayling latency score

Note. Model-predicted values are presented, controlling for education level. Longer latency on
the Hayling reflects poorer inhibition skills.
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Figure 2. Curvilinear association between CGG repeat length and the BRIEF-A Inhibit subscale

Note. Model-predicted values are presented, controlling for education level. Higher t-scores on
the Inhibit subscale reflect poorer inhibition skills.
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Figure 3. Effect of age on the Hayling latency score

Note. Model-predicted values are presented, controlling for education level. Longer latency on
the Hayling reflects poorer inhibition skills.
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